Drug Classifications Nursing Related

Review Drug Classifications Nursing related questions and content

Long-acting beta-agonists (LTBAs) received a Black Box Warning from the U.S. Food and Drug Administration due to the:

  • A. Risk of life-threatening dermatological reactions
  • B. Increased incidence of cardiac events when LTBAs are used
  • C. Increased risk of asthma-related deaths when LTBAs are used
  • D. Risk for life-threatening alterations in electrolytes
Correct Answer: C

Rationale: The FDA Black Box Warning for LTBAs highlights increased asthma-related mortality risk, not dermatologic , cardiac , or electrolyte issues.